NCT03858257View on ClinicalTrials.gov

High Flow Nasal Oxygen During Sedation

NACompletedINTERVENTIONAL
Enrollment

129

Participants

Timeline

Start Date

August 7, 2019

Primary Completion Date

March 12, 2020

Study Completion Date

March 12, 2020

Conditions
AnesthesiaCardiac Disease
Interventions
DEVICE

High flow nasal oxygen

The Optiflow device (Fisher and Paykel Healthcare, Auckland, New Zealand) will be used.

DEVICE

Standard oxygenation

Supplemental oxygen through a facemask.

Trial Locations (1)

Unknown

Toronto General Hospital, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT03858257 - High Flow Nasal Oxygen During Sedation | Biotech Hunter | Biotech Hunter